The study did not identify a relevant role for the KRAS mutations on prognosis, but the authors provided evidence that CIMP high appears to be an independent predictor of a low CRC specific mortality, while BRAF mutations are associated with a high CRC specific mortality [53]. Here, KRAS is linked to colorectal carcinoma.